Spruce Biosciences Inc.
0.37
-0.00 (-0.38%)
At close: Jan 15, 2025, 3:59 PM
0.36
-1.49%
After-hours Jan 15, 2025, 04:27 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -2.35 -0.57 -2.44 -18.83 -28.59 -8.44
PS Ratio 11.18 n/a n/a n/a n/a n/a
PB Ratio 1.47 0.38 0.94 3.78 -12.35 -4.67
P/FCF Ratio -3.39 -0.62 -2.9 -20.49 -29.99 -9.71
P/OCF Ratio -3.39 -0.62 -2.9 -20.55 -30 -9.71
OCF/S Ratio -3.3 n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.06 0.09 0.06 0.04 -0.15 n/a
Quick Ratio 4.18 6.72 10.36 16.43 1.08 1.76
Current Ratio 4.18 6.72 10.36 16.43 1.08 1.76
Asset Turnover 0.10 n/a n/a n/a n/a n/a
Interest Coverage -107.65 -112.58 -121.93 -91.07 -201.65 n/a
Return on Equity (ROE) -0.63 -0.66 -0.38 -0.2 0.43 0.55
Return on Assets (ROA) -0.46 -0.53 -0.34 -0.18 -2.82 -2.06
Return on Capital (ROIC) -0.65 -0.65 -0.36 -0.19 -33.69 -4.82
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin -389.96% n/a n/a n/a n/a n/a
Net Profit Margin -474.96% n/a n/a n/a n/a n/a
Pretax Profit Margin -474.96% n/a n/a n/a n/a n/a
Operating Profit Margin -515.34% n/a n/a n/a n/a n/a
FCF Margin -329.88% n/a n/a n/a n/a n/a
EBITDA Margin -469.48% n/a n/a n/a n/a n/a